Protalix BioTherapeutics
PLX
#8626
Rank
$0.12 B
Marketcap
$1.76
Share price
1.15%
Change (1 day)
-2.22%
Change (1 year)

Protalix BioTherapeutics (PLX) - Net assets

Net assets on the balance sheet as of September 2024 : $32.43 Million USD

According to Protalix BioTherapeutics 's latest financial reports the company has $32.43 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Protalix BioTherapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$33.56 M-415.5%
2022-12-31$-$10.64 Million76.28%
2021-12-31$-$6.04 Million-77.68%
2020-12-31$-$27.04 Million-61.55%
2019-12-31$-$70.33 Million32.98%
2018-12-31$-$52.89 Million79.52%
2017-12-31$-$29.46 Million195.84%
2016-12-31$-$9.96 Million-191.58%
2015-12-31$$10.87 M-119.56%
2014-12-31$-$55.61 Million106.34%
2013-12-31$-$26.95 Million702.68%
2012-12-31$-$3.36 Million-87.13%
2011-12-31$-$26.08 Million130.3%
2010-12-31$-$11.33 Million-171.29%
2009-12-31$$15.88 M-64.18%
2008-12-31$$44.34 M-30.37%
2007-12-31$$63.68 M162.25%
2006-12-31$$24.28 M298.42%
2005-12-31$$6.09 M1131.31%
2004-12-31$$0.49 M-24.48%
2003-12-31$$0.65 M-17.67%
2002-12-31$$0.79 M-15.83%
2001-12-31$$0.94 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$0.17 B 451.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.71 B 8,282.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$92.55 B 285,246.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.38 B 19,581.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel